Stocks›Consumer Cyclical›PETS

PETS

PetMed Express, Inc.
NasdaqResearch view

PetMed Express, Inc. operates in the Retail-Drug Stores And Proprietary Stores industry.

$1.32−2.94%
Oct 5 close · 1D EOD · Databento
Consumer CyclicalRetail-Drug Stores And Proprietary StoresMicro-capSEC EDGAR FY 2026-03-31

The numbers · FY2026, filed

SEC EDGAR
Market cap$29M
Revenue$179.0M−21.10%
Net income$-57.3M
EPS, diluted$-2.74−813.30%
Gross margin28.1%
Operating margin-32.8%
All filed figures

Snapshot

SEC EDGAR · FY 2026-03-31
SectorConsumer Cyclical
Market Cap$29.5M
Enterprise Value$8.1M
Income$-57.3M
Sales$179.0M
Book/sh$1.33
Cash/sh$0.99
Dividend TTM$0.00
Payout0%
Employees—
IPO—
Quick Ratio0.58
Current Ratio0.84
Debt/Eq—
EPS (ttm)$-2.74
EPS this Y-813.3%
EPS past 3/5Y—
Sales past 3/5Y-10.2%
EPS Y/Y TTM-813.3%
Sales Y/Y TTM-21.1%
Shs Outstand21.68M
ROA-70.6%
ROE-198.0%
ROIC-778.4%
Gross Margin28.1%
Oper. Margin-32.8%
Profit Margin-32.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$272.3M
FY22
$247.6M
FY23
$274.1M
FY24
$227.0M
FY25
$179.0M
FY26

Operating leverage — margins

GrossOperatingNet
0%40%80%28%-33%-32%FY22FY23FY24FY25FY26
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2022FY2023FY2024FY2025FY2026

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.